A double-blind, placebo-controlled multicentre trial of memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies
- Prosjektnummer
- 911346
- Ansvarlig person
- Dag Årsland
- Institusjon
- Helse Stavanger HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Mental Health
- Forskningsaktivitet
- 6. Treatment Evaluation
Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.
Int J Geriatr Psychiatry 2011 Feb;26(2):206-13.
PMID: 20665553
Quality of Life and the Effect of Memantine in Dementia with Lewy Bodies and Parkinson's Disease Dementia.
Dement Geriatr Cogn Disord 2011 Nov;32(4):227-234. Epub 2011 nov 25
PMID: 22122992
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia.
Int J Geriatr Psychiatry 2010 Oct;25(10):1030-8.
PMID: 20872929
CSF amyloid ß38 as a novel diagnostic marker for dementia with Lewy bodies.
J Neurol Neurosurg Psychiatry 2011 Feb;82(2):160-4. Epub 2010 nov 3
PMID: 21047883
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.
Lancet Neurol 2009 Jul;8(7):613-8. Epub 2009 jun 10
PMID: 19520613
A double-blind, placebo-controlled multicentre trial of memantine in patients with Parkinson’s disease dementia and dementia wit
MDS 13th International Congress, Paris, June
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest